IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishPharmacologic treatment of myocardial ischemia in patients with chronic stable angina (CSA) is mainly based on heart rate lowering drugs and vasodilator agents. Other drugs are available, however, that act by some peculiar mechanism (ranolazine, trimetazidine) and may add potential anti-ischemic and anti-anginal effects to standard therapeutic mechanisms. While anti-ischemic agents are crucial for controlling angina symptoms and improving quality of life, whether myocardial ischemia portends an ominous prognosis and its suppression improves clinical outcome in CSA patients remain debated issues.
Lanza, G. A., Crea, F., Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach, <<CARDIOVASCULAR DRUGS AND THERAPY>>, 2016; 30 (4): 341-349. [doi:10.1007/s10557-016-6662-5] [http://hdl.handle.net/10807/98559]
| Autori: | ||
| Titolo: | Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/s10557-016-6662-5 | |
| URL: | www.wkap.nl/journalhome.htm/0920-3206 | |
| Data di pubblicazione: | 2016 | |
| Abstract: | Pharmacologic treatment of myocardial ischemia in patients with chronic stable angina (CSA) is mainly based on heart rate lowering drugs and vasodilator agents. Other drugs are available, however, that act by some peculiar mechanism (ranolazine, trimetazidine) and may add potential anti-ischemic and anti-anginal effects to standard therapeutic mechanisms. While anti-ischemic agents are crucial for controlling angina symptoms and improving quality of life, whether myocardial ischemia portends an ominous prognosis and its suppression improves clinical outcome in CSA patients remain debated issues. | |
| Lingua: | Inglese | |
| Rivista: | ||
| Citazione: | Lanza, G. A., Crea, F., Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach, <<CARDIOVASCULAR DRUGS AND THERAPY>>, 2016; 30 (4): 341-349. [doi:10.1007/s10557-016-6662-5] [http://hdl.handle.net/10807/98559] | |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2021